FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089079743> ?p ?o ?g. }

• W3089079743 endingPage "9609" @default.
• W3089079743 startingPage "9599" @default.
• W3089079743 abstract "EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2) and has been documented as an oncogene in breast cancer. The microRNA (miR)-101-3p can suppress breast cancer progression by targeting with EZH2. Syn-cal14.1a, a synthetic peptide derived from Californiconus californicus (Cal14.1a), can decrease the cell viability and activate the cell apoptosis in cancer. In this study, we explored whether the synergy of miR-101-3p mimic and syn-cal14.1a could inhibit the expression of EZH2. We also investigated this binding treatment's effects on the suppression of breast cancer cells.MiR-101-3p mimic was transfected and syn-cal14.1a was added in SK-BR-3 and MCF-7 breast cancer cells. The expression of EZH2 protein level was determined. Then, cell proliferation, migration, invasion, and apoptosis were observed.MiR-101-3p and syn-cal14.1a, when applied together, exerted a synergistic anti-EZH2 expression in breast cancer cells. The combination of miR-101-3p and syn-cal14.1a synergistically suppressed the EZH2-induced breast cancer cell migration, invasion, and proliferation. In parallel, this synergy treatment was able to promote the apoptosis of breast cancer cells. To our knowledge, this is the first report describing inhibition of EZH2 in human breast cancer cell lines by syn-cal14.1a.The anti-EZH2 roles of miR-101-3p and/or syn-cal14.1a could provide an effective therapeutic strategy in breast cancer. These data provide significant insights into molecular mechanisms of breast cancer and may have benefits in clinical therapeutics for breast cancer." @default.
• W3089079743 created "2020-10-01" @default.
• W3089079743 creator A5027475930 @default.
• W3089079743 creator A5032122445 @default.
• W3089079743 creator A5058062980 @default.
• W3089079743 creator A5063216264 @default.
• W3089079743 creator A5065418938 @default.
• W3089079743 creator A5076940713 @default.
• W3089079743 creator A5086194703 @default.
• W3089079743 date "2020-09-01" @default.
• W3089079743 modified "2023-09-25" @default.
• W3089079743 title "<p>MiR-101-3p and Syn-Cal14.1a Synergy in Suppressing EZH2-Induced Progression of Breast Cancer</p>" @default.
• W3089079743 cites W144423133 @default.
• W3089079743 cites W1551999069 @default.
• W3089079743 cites W1865495681 @default.
• W3089079743 cites W1957162308 @default.
• W3089079743 cites W1972435958 @default.
• W3089079743 cites W1980422148 @default.
• W3089079743 cites W1990232520 @default.
• W3089079743 cites W1999505686 @default.
• W3089079743 cites W2004380688 @default.
• W3089079743 cites W2004380823 @default.
• W3089079743 cites W2014291825 @default.
• W3089079743 cites W2015132841 @default.
• W3089079743 cites W2026057304 @default.
• W3089079743 cites W2029427254 @default.
• W3089079743 cites W2040182688 @default.
• W3089079743 cites W2042237007 @default.
• W3089079743 cites W2052956415 @default.
• W3089079743 cites W2060608189 @default.
• W3089079743 cites W2091645561 @default.
• W3089079743 cites W2099869529 @default.
• W3089079743 cites W2100365251 @default.
• W3089079743 cites W2140116051 @default.
• W3089079743 cites W2144149602 @default.
• W3089079743 cites W2147247243 @default.
• W3089079743 cites W2168083201 @default.
• W3089079743 cites W2258843132 @default.
• W3089079743 cites W2263927213 @default.
• W3089079743 cites W2320983896 @default.
• W3089079743 cites W2334691597 @default.
• W3089079743 cites W2336448232 @default.
• W3089079743 cites W2549976854 @default.
• W3089079743 cites W2562767337 @default.
• W3089079743 cites W2568422800 @default.
• W3089079743 cites W2804013341 @default.
• W3089079743 cites W2972753415 @default.
• W3089079743 cites W3004723659 @default.
• W3089079743 cites W3006197480 @default.
• W3089079743 cites W3014126386 @default.
• W3089079743 cites W4211214747 @default.
• W3089079743 cites W4230705206 @default.
• W3089079743 doi "https://doi.org/10.2147/ott.s264600" @default.
• W3089079743 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7532305" @default.
• W3089079743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33061442" @default.
• W3089079743 hasPublicationYear "2020" @default.
• W3089079743 type Work @default.
• W3089079743 sameAs 3089079743 @default.
• W3089079743 citedByCount "8" @default.
• W3089079743 countsByYear W30890797432021 @default.
• W3089079743 countsByYear W30890797432022 @default.
• W3089079743 countsByYear W30890797432023 @default.
• W3089079743 crossrefType "journal-article" @default.
• W3089079743 hasAuthorship W3089079743A5027475930 @default.
• W3089079743 hasAuthorship W3089079743A5032122445 @default.
• W3089079743 hasAuthorship W3089079743A5058062980 @default.
• W3089079743 hasAuthorship W3089079743A5063216264 @default.
• W3089079743 hasAuthorship W3089079743A5065418938 @default.
• W3089079743 hasAuthorship W3089079743A5076940713 @default.
• W3089079743 hasAuthorship W3089079743A5086194703 @default.
• W3089079743 hasBestOaLocation W30890797431 @default.
• W3089079743 hasConcept C104317684 @default.
• W3089079743 hasConcept C121608353 @default.
• W3089079743 hasConcept C126322002 @default.
• W3089079743 hasConcept C145059251 @default.
• W3089079743 hasConcept C1491633281 @default.
• W3089079743 hasConcept C185592680 @default.
• W3089079743 hasConcept C190283241 @default.
• W3089079743 hasConcept C2776915012 @default.
• W3089079743 hasConcept C2781018059 @default.
• W3089079743 hasConcept C29537977 @default.
• W3089079743 hasConcept C41091548 @default.
• W3089079743 hasConcept C50171091 @default.
• W3089079743 hasConcept C502942594 @default.
• W3089079743 hasConcept C530470458 @default.
• W3089079743 hasConcept C54009773 @default.
• W3089079743 hasConcept C54355233 @default.
• W3089079743 hasConcept C55493867 @default.
• W3089079743 hasConcept C62112901 @default.
• W3089079743 hasConcept C71924100 @default.
• W3089079743 hasConcept C81885089 @default.
• W3089079743 hasConcept C86803240 @default.
• W3089079743 hasConcept C96232424 @default.
• W3089079743 hasConceptScore W3089079743C104317684 @default.
• W3089079743 hasConceptScore W3089079743C121608353 @default.
• W3089079743 hasConceptScore W3089079743C126322002 @default.
• W3089079743 hasConceptScore W3089079743C145059251 @default.
• W3089079743 hasConceptScore W3089079743C1491633281 @default.

• next